Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,779 total articles

Inspira Technologies Secures Fully Paid $390,000  Purchase Order and Recurring Revenue Stream from Premier APAC University

Inspira Technologies Secures Fully Paid $390,000 Purchase Order and Recurring Revenue Stream from Premier APAC University

Inspira Technologies announced receipt of a fully paid $390,000 purchase order for its additive manufacturing electronics (AME) system from a premier Asia-Pacific technological research university specializing in quantum computing. The purchase establishes a recurring revenue stream through consumables and service fees. Inspira's AME technology sup…

Silexion Therapeutics Announces Successful Submission of Phase 2/3 Clinical Trial Application to Germany’s BfArM for SIL204 in KRAS-Driven Locally Advanced Pancreatic Cancer

Silexion Therapeutics Announces Successful Submission of Phase 2/3 Clinical Trial Application to Germany’s BfArM for SIL204 in KRAS-Driven Locally Advanced Pancreatic Cancer

Silexion Therapeutics has successfully submitted a Clinical Trial Application to Germany's BfArM for its Phase 2/3 study of SIL204, an innovative siRNA therapy targeting KRAS-driven locally advanced pancreatic cancer. This regulatory milestone follows Israeli approval and marks the company's expansion into the European clinical development landscap…

Shimmick Corporation Appoints Sarah Tacker as Executive Vice President and Chief Operating Officer

Shimmick Corporation Appoints Sarah Tacker as Executive Vice President and Chief Operating Officer

Shimmick Corporation (NASDAQ: SHIM), a leading infrastructure solutions company, announced the appointment of Sarah Tacker as Executive Vice President and Chief Operating Officer. With 27 years of construction industry experience, Ms. Tacker will lead the company’s operational functions to improve execution and support scaling efforts. This strateg…

Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs

Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs

Quoin Pharmaceuticals has announced plans to initiate several investigator-led clinical studies for its QRX009 topical rapamycin lotion targeting rare skin diseases including Pachyonychia Congenita, Gorlin Syndrome, and Tuberous Sclerosis Complex. The company expects to submit an Investigational New Drug Application to the FDA for an additional ind…

GSI Technology Awarded U.S. Army xTech SBIR Contract to Develop Ruggedized Edge AI Platform for Tactical Defense Applications

GSI Technology Awarded U.S. Army xTech SBIR Contract to Develop Ruggedized Edge AI Platform for Tactical Defense Applications

GSI Technology, a pioneer in Associative Processing Unit (APU) technology, announced it has been awarded a Phase-II U.S. Army xTech SBIR contract valued at approximately $2 million to develop a ruggedized edge AI platform using its Gemini-II APU. The contract supports the design, fabrication, and validation of a low-power, high-performance AI proce…

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

Nuwellis, Inc. announced the receipt of a Notice of Allowance from the USPTO for its innovative dual lumen midline catheter technology designed to optimize ultrafiltration therapy. The patented catheter features advanced design elements that improve blood flow and customize catheter length for diverse patient anatomies, aiming to enhance patient ou…

PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting

PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting

PolyPid Ltd., a biopharmaceutical company listed on Nasdaq, announced upcoming presentation of detailed analysis from its Phase 3 SHIELD II trial at the 2026 Surgical Infection Society Annual Meeting. The data demonstrate a statistically significant reduction in both the incidence and severity of surgical site infections (SSI) following colorectal …

TruGolf LINKS REGIONAL DEVELOPER SIGNS LEASE FOR FIRST LOCATION

TruGolf LINKS REGIONAL DEVELOPER SIGNS LEASE FOR FIRST LOCATION

TruGolf Inc., a Nasdaq-listed company specializing in high-tech golf simulators, announced the signing of a lease for its first flagship TruGolf Links Center on Long Island, located in Westbury, New York. The new 4,011 square foot facility will feature upscale golf simulators, a restaurant, and full bar, aiming to open this Fall. The initiative is …

Btab Launches Agentic AI to Power Its Global Product Reseller Network

Btab Launches Agentic AI to Power Its Global Product Reseller Network

Btab Ecommerce Group, Inc. announced the launch of its Agentic AI initiative designed to automate and support its global product reseller network. The AI agents will assist with store setup, product listings, customer engagement, pricing, marketing, and sales optimization, aimed at making ecommerce more accessible to novices and small business owne…

Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio

Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio

Jyong Biotech Ltd. announced progress in market access strategies for its botanical drug candidates Botreso® and PCP, highlighting successful Phase III and II clinical trials respectively. The data underscore significant safety and efficacy advantages over synthetic drugs including potential for prostate cancer prevention and metabolic benefits. Th…

TOMI Environmental Solutions to Present at Wall Street Reporter’s NEXT SUPER STOCK Livestream Today, April 28, 2026, at 1 p.m. ET

TOMI Environmental Solutions to Present at Wall Street Reporter’s NEXT SUPER STOCK Livestream Today, April 28, 2026, at 1 p.m. ET

TOMI Environmental Solutions, a NASDAQ-listed leader in disinfection technology, announced that CEO Dr. Halden Shane will present at a livestream event hosted by Wall Street Reporter. The presentation will cover TOMI’s innovation acceleration business model and provide an update on company operations. The event includes a Q&A session and aims to en…

Fabric.AI (Nasdaq: SBLX) Launches Breakthrough MicroLED Interconnect Technology as First Step in Building Next-Generation “AI Factory” Infrastructure. Partners with Leading MicroLED Developer Kopin Corporation (Nasdaq: KOPN)

Fabric.AI (Nasdaq: SBLX) Launches Breakthrough MicroLED Interconnect Technology as First Step in Building Next-Generation “AI Factory” Infrastructure. Partners with Leading MicroLED Developer Kopin Corporation (Nasdaq: KOPN)

Fabric.AI, formerly StableX Technologies, has introduced a breakthrough MicroLED-based optical interconnect technology designed to overcome data transmission bottlenecks in AI computing, in collaboration with Kopin Corporation. The company aims to build a suite of fabless semiconductor technologies powering next-generation AI 'factories' or smart d…

Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million

Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million

Enlivex Ltd. announced an increase in its holdings of RAIN tokens to approximately 78.8 billion tokens valued at $567 million as of April 27, 2026. The company acquired these tokens at a discounted price via its option with the Rain Foundation, highlighting its disciplined treasury strategy in prediction markets. Enlivex combines its clinical-stage…

CLICK (NASDAQ: CLIK) Secures Low-Cost Entry into the US$300B Greater Bay Area Silver Economy via Flash Mutual Acquisition, US$2.5M Profit Guarantee & “Life Care Robot” Expected to Deliver Over 50% Incremental Profit Surge in 2027

CLICK (NASDAQ: CLIK) Secures Low-Cost Entry into the US$300B Greater Bay Area Silver Economy via Flash Mutual Acquisition, US$2.5M Profit Guarantee & “Life Care Robot” Expected to Deliver Over 50% Incremental Profit Surge in 2027

Click Holdings Limited announced it has signed a memorandum of understanding to acquire a 15% stake in Flash Mutual Technology for US$0.64 million, marking its entry into the Greater Bay Area (GBA) silver economy, particularly focusing on Guangzhou and surrounding areas. Flash Mutual Guangdong has deployed AI-driven elderly care solutions with stro…

NANO Nuclear Sees KRONOS MMR™ Well-Aligned with NRC’s Evolving Advanced Reactor Frameworks Under Part 53 and Proposed Part 57

NANO Nuclear Sees KRONOS MMR™ Well-Aligned with NRC’s Evolving Advanced Reactor Frameworks Under Part 53 and Proposed Part 57

NANO Nuclear Energy Inc. highlights the regulatory advancements by the U.S. Nuclear Regulatory Commission (NRC) with the final Part 53 rule and the proposed Part 57 framework. These rules introduce a risk-informed, performance-based, and technology-inclusive licensing approach facilitating the deployment of advanced nuclear reactors, specifically m…

Itron Announces First Quarter 2026 Financial Results

Itron Announces First Quarter 2026 Financial Results

Itron, Inc. announced its financial results for Q1 2026, showing a 3% revenue decline to $587 million primarily due to portfolio optimization and project timing, offset by a 5% increase in adjusted EBITDA and stronger free cash flow. The company's adjusted gross margin improved significantly to 40.7%. Net income decreased compared to last year, imp…

T3 Defense CEO Converts $2.14 Million of Debt into Equity, Reducing Outstanding Debt and Strengthening Balance Sheet

T3 Defense CEO Converts $2.14 Million of Debt into Equity, Reducing Outstanding Debt and Strengthening Balance Sheet

T3 Defense Inc. announced that its CEO and Chairman, Menachem Shalom, has converted $2.14 million of promissory notes into approximately 4.1 million restricted shares of common stock. This conversion eliminates near-term debt repayment obligations, improves the capital structure, and aligns the CEO’s interests with shareholders. The move comes amid…

Consensus Reached, Ready for Launch: Baiya International Group Inc.’s “Ark Plan” Sets First Destination on BNB

Consensus Reached, Ready for Launch: Baiya International Group Inc.’s “Ark Plan” Sets First Destination on BNB

Baiya International Group Inc. (Nasdaq: BIYA) announced the launch of its Cryptocurrency Ark Plan, designating Binance Coin (BNB) as its initial core digital asset following a public vote. The plan involves a $1 million initial purchase using four simultaneous trading strategies to manage volatility and capture gains. The company also reserved addi…

Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development

Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development

Artelo Biosciences announced a strategic collaboration with AI company ScienceMachine to leverage their advanced AI platform for analyzing large biological datasets related to Artelo's FABP5 inhibitor program. This partnership aims to expedite the identification of new therapeutic mechanisms, biomarkers, and drug candidates, particularly for ART26.…